4.5 Article

Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells

期刊

HUMAN MOLECULAR GENETICS
卷 25, 期 2, 页码 254-265

出版社

OXFORD UNIV PRESS
DOI: 10.1093/hmg/ddv468

关键词

-

资金

  1. National Institutes of Health [MSTP/T32/65841, NCATS/TL1/TR000137, OD007015-01]
  2. Todd and Karen Wanek Family Foundation for Hypoplastic Left Heart Syndrome
  3. Minnesota Regenerative Medicine Grant [MRM/2015/GSCH/003]

向作者/读者索取更多资源

Dilated cardiomyopathy (DCM) is a leading cause of heart failure. In families with autosomal-dominant DCM, heterozygous missense mutations were identified in RNA-binding motif protein 20 (RBM20), a spliceosome protein induced during early cardiogenesis. Dermal fibroblasts from two unrelated patients harboring an RBM20 R636S missense mutation were reprogrammed to human induced pluripotent stem cells (hiPSCs) and differentiated to beating cardiomyocytes (CMs). Stagespecific transcriptome profiling identified differentially expressed genes ranging from angiogenesis regulator to embryonic heart transcription factor as initial molecular aberrations. Furthermore, gene expression analysis for RBM20-dependent splice variants affected sarcomeric (TTN and LDB3) and calcium (Ca2+) handling (CAMK2D and CACNA1C) genes. Indeed, RBM20 hiPSCCMs exhibited increased sarcomeric length (RBM20: 1.747 +/- 0.238 mu m versus control: 1.404 +/- 0.194 mu m; P < 0.0001) and decreased sarcomeric width (RBM20: 0.791 +/- 0.609 mu m versus control: 0.943 +/- 0.166 mu m; P < 0.0001). Additionally, CMs showed defective Ca2+ handling machinery with prolonged Ca2+ levels in the cytoplasm as measured by greater area under the curve (RBM20: 814.718 +/- 94.343 AU versus control: 206.941 +/- 22.417 AU; P < 0.05) and higher Ca2+ spike amplitude (RBM20: 35.281 +/- 4.060 AU versus control: 18.484 +/- 1.518 AU; P < 0.05). beta-adrenergic stress induced with 10 mu M. norepinephrine demonstrated increased susceptibility to sarcomeric disorganization (RBM20: 86 +/- 10.5% versus control: 40 +/- 7%; P < 0.001). This study features the first hiPSC model of RBM20 familial DCM. By monitoring human cardiac disease according to stage-specific cardiogenesis, this study demonstrates RBM20 familial DCM is a developmental disorder initiated by molecular defects that pattern maladaptive cellular mechanisms of pathological cardiac remodeling. Indeed, hiPSC-CMs recapitulate RBM20 familial DCM phenotype in a dish and establish a tool to dissect disease-relevant defects in RBM20 splicing as a global regulator of heart function.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据